Revolution Aspire CT System is manufactured at the company’s new plant launched under the government’s Production Linked Incentives (PLI) Scheme
Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
The company inaugurated the new production line at the Bengaluru facility to manufacture Computed Tomography Scanners
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore
A total of 21 applicants have been approved for 49 products, with the potential to utilize an incentive amount of Rs. 2541 crore
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
Biocon has reported consolidated financial results for the period ended December 31, 2021
Approvals accorded under Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ drug intermediates and Active Pharmaceutical Ingredients (APIs
Subscribe To Our Newsletter & Stay Updated
